Medicinal cannabis in Australia: the missing links
Authors: Albert S Reece and Gary K Hulse
Published online: 7 November 2016
The well researched article by Martin and Bonomo1 may provide the Australian government with the kind of safety and efficacy data mandatory for all new drugs marketed to human populations. However, the authors did not discuss the efficacy of cannabis compared with that of accepted safe medicines; this applies to most of the indications that have been alleged but not proven for cannabis, including pain, spasticity, anticonvulsant action, weight gain and antiglaucoma agents.
In Australia, leading cannabis advocates champion generalised drug legalisation,2 and in New South Wales there is a specific Medicinal Cannabis Compassionate Use Scheme, which relates to patients in terminal care with consideration being given to extending its use to patients who are non-terminal.3
However, personal criticisms may stifle the necessary academic debate and rigorous assessment that are applied to any other proposed medication. It seems counter-evidentiary that while a leading international addiction science administrator issues cautionary statements on cannabis (relating particularly to neurological, developmental, driving, respiratory, lifetime trajectory and pro-addiction effects),4 professional leaders in this country may endure personal attacks. As authors of a cautionary article on the causal implication of cannabis in the genotoxic heritable mutagenicity and carcinogenicity in exposed individuals and their offspring,5 we have faced similar criticism.
When those who claim to be authorities of addiction medicine refer to themselves as the Nimbin Health and Medical Research Council,6 something is awry. What is required is a considered debate based on current empirical data and not decisions pushed by idealistic groups. As George Santayana wrote in another context: “Those who do not learn from history are doomed to repeat it”.
References
- Martin JH, Bonomo YA. Medicinal cannabis in Australia: the missing links. Med J Aust 2016; 204: 371-373.
- Marijuana (HEMP) Party [website]. Let’s do cannabis better. Nimbin: HEMP Party; 2016. https://australianhempparty.com/ (accessed Sept 2016).
- Centre for Medicinal Cannabis Research and Innovation [website]. Medicinal Cannabis Compassionate Use Scheme. Sydney: New South Wales Government; 2016. https://www.medicinalcannabis.nsw.gov.au/regulation/medicinal-cannabis-compassionate-use-scheme (accessed Sept 2016).
- Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219-2227.
- Reece AS, Hulse GK. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res 2016; 789: 15-25.
- Wodak A. Don’t endanger yourself with dope: cannabis Sydney: The Australian; 2009. http://adlrf.org.au/dont-endanger-yourself-with-dope-cannabis/ (accessed June 2016).
Getting on the Same Page: Why Australia Needs a National Maternity Early Warning System (MEWS) Chart
Briony A. Cutts, Lucy Bowyer, Nisha Khot, Sandra Lowe, Stefan C. Kane
Data for Equity: Can Linked Administrative Data Inform Pathways to More Equitable Child Health?
Sarah Gray, Shuaijun Guo, Meredith O'Connor, Elodie O'Connor, Katrina Williams, Hannah Badland, Susan Woolfenden, Josie Dickerson, Gerry Redmond, Marnie Downes, Sharon R. Goldfeld
Specialty College Selection: Why Change is Critical to Support a Future Rural Workforce
Matthew R. McGrail, Jenny May AM, Katherine Logan
The number of cancer‐related deaths that could be attributable to spatial disparities in survival in Australia, 2010–2019: a retrospective population‐based cohort study
Charlotte K Bainomugisa, Jessica Cameron, Paramita Dasgupta, Peter Baade
Differentiated and simplified oral HIV pre‐exposure prophylaxis (PrEP) models hold the key to virtually eliminating HIV transmission in Australia by 2030
Tyson Arapali, Sarah Warzywoda, Anthony K J Smith, Curtis Chan, Timothy R Broady, Erin Sullivan, Catherine MacPhail, Mohamed A Hammoud, Alexander Dowell‐Day, Benjamin R Bavinton
Non‐technical errors associated with deaths in surgical care, Australia, 2012–2019, by surgical specialty (Australian and New Zealand Audit of Surgical Mortality): a retrospective cohort study
Jesse Ey, Victoria Kollias, Octavia Lee, Kelly Hou, Matheesha Herath, John B North, Ellie Treloar, Suzanne Edwards, Martin Bruening, Adam J Wells, Guy J Maddern